CITIRAJ
Zafirović S, Macvanin M, Stanimirović J, Obradović M, Radovanović J, Melih I. Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity. Current Vascular Pharmacology. 2022;20(6):465–474.
Zafirović, S., Macvanin, M., Stanimirović, J., Obradović, M., Radovanović, J., & Melih, I. (2022). Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity. Current Vascular Pharmacology, 20(6), 465–474. https://doi.org/10.2174/1570161120666220819164
Zafirović, S., Macvanin, M., Stanimirović, J., Obradović, M., Radovanović, J. and Melih, I. (2022) 'Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity', Current Vascular Pharmacology, 20(6), pp. 465–474.
@article{zafirovic2022_751,
author = {Zafirović, Sonja and Macvanin, Mirjana and Stanimirović, Julijana and Obradović, Milan and Radovanović, Jelena and Melih, Irena},
title = {Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity},
journal = {Current Vascular Pharmacology},
year = {2022},
volume = {20},
number = {6},
pages = {465--474},
doi = {10.2174/1570161120666220819164},
issn = {1570-1611}
}
TY - JOUR
AU - Zafirović, Sonja
AU - Macvanin, Mirjana
AU - Stanimirović, Julijana
AU - Obradović, Milan
AU - Radovanović, Jelena
AU - Melih, Irena
TI - Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity
T2 - Current Vascular Pharmacology
PY - 2022
VL - 20
IS - 6
SP - 465
EP - 474
DO - 10.2174/1570161120666220819164
SN - 1570-1611
ER -
